Search Results 1881-1890 of 16521 for Maximum

  1. Safety and Efficacy Study of PRI-724 in Subjects With Advanced Solid Tumors - Mayo Clinic

    The MTD cohort (or maximum dose to be studied) will be expanded up to 12 patients. Participation eligibility. Participant eligibility includes age, gender ...

  2. Neurology - Clinical trials

    The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

  3. 64Cu-SAR-bisPSMA And 67Cu-SAR-bisPSMA For Identification And Treatment Of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE) - Mayo Clinic

    Note: Taxane exposure (maximum 6 cycles) in the adjuvant or neoadjuvant setting is allowed if 12 months have elapsed since completion of this adjuvant or ...

  4. Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma - Mayo Clinic

    NOTE: patients may be receiving stable doses of corticosteroids with a maximum dose of 10 mg of prednisone per day if they are being given for disorders ...

  5. First-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid Tumors - Mayo Clinic

    This first-in-human study is conducted to identify the maximum tolerated dose (MTD) and dose-limiting toxicities (DLTs) of TP-0903 administered orally to ...

  6. Advancements in opioids research, transformations in postsurgical prescribing - Mayo Clinic News Network

    At the time of this work, acute pain, including post-surgical pain, was treated by opioid prescriptions up to a maximum post-surgery or acute injury ...

  7. T2 Lens Study - Mayo Clinic

    Ability to safely engage in a laboratory-run assessment of maximum VO2 consumption. No contraindications per the 2023 PAR-Q+ physical activity readiness ...

  8. Clinical trials - Oncology (Medical)

    ... maximum) over a period of 12 months * Visit the clinic three times for the first week of cycle one, then once a week for the remaining 7 weeks of cycle 1 ...

  9. Gastroenterology and Hepatology - Clinical trials

    Difference in gastric emptying (T1/2, emptying at 2h and emptying at 4h);; Volume to fullness (sensation of usual postprandial fullness) and maximum feeling of ...

  10. A Multi-center Study to Evaluate the Safety, Tolerability and Efficacy of TIN816 in Patients at Risk for Acute Kidney Injury Following Cardiac Surgery - Mayo Clinic

    - Male and female patients ≥ 45 years at screening. - Participants must weigh at least 50 kg and maximum 150 kg to participate in the study and must have a ...